SCHEMBL21841075

SCHEMBL21841075

c1ccc(-c2ccc(-c3cc(-c4ccc5ccc6cccnc6c5n4)cc(-c4ccc(-c5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 6/20 0.53
▸ CYP19A1 P11511 1/20 0.49
▸ CCR1 P32246 2/20 0.48
▸ CCR5 P51681 2/20 0.48
▸ CCR8 P51685 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MMP2 P08253 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ GMNN O75496 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ MMP9 P14780 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ MMP8 P22894 1/20 0.48
▸ THPO P40225 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29192757 0.91 LMNA (0.59) TOP1CCR1CCR5CCR8KDM4E
SCHEMBL30837267 0.91 LMNA (0.59) TOP1CCR1CCR5CCR8KDM4E
SCHEMBL26200013 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL26199941 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL19762971 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL19762930 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL19762973 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL19762991 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL25780004 0.90 TOP1 (0.51) TOP1CYP19A1CCR1CCR5CCR8
SCHEMBL30112679 0.89 KDM4E (0.53) TOP1CYP19A1CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200095224-A1 NITROGEN HETEROCYCLIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095224-A1 NITROGEN HETEROCYCLIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS C5, CCND2, OCIAD2 TOP1 639/4885CYP19A1 506/4885CCR1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback